These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

260 related articles for article (PubMed ID: 32986074)

  • 21. Adverse Events Involving Radiation Oncology Medical Devices: Comprehensive Analysis of US Food and Drug Administration Data, 1991 to 2015.
    Connor MJ; Marshall DC; Moiseenko V; Moore K; Cervino L; Atwood T; Sanghvi P; Mundt AJ; Pawlicki T; Recht A; Hattangadi-Gluth JA
    Int J Radiat Oncol Biol Phys; 2017 Jan; 97(1):18-26. PubMed ID: 27979446
    [TBL] [Abstract][Full Text] [Related]  

  • 22. FDA modernization act of 1997: guidance on medical device tracking; availability--FDA. Notice.
    Fed Regist; 1998 Mar; 63(42):10640-1. PubMed ID: 10177505
    [TBL] [Abstract][Full Text] [Related]  

  • 23. FDA approval of cardiac implantable electronic devices via original and supplement premarket approval pathways, 1979-2012.
    Rome BN; Kramer DB; Kesselheim AS
    JAMA; 2014 Jan 22-29; 311(4):385-91. PubMed ID: 24449317
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Sources of Evidence Triggering and Supporting Safety-Related Labeling Changes: A 10-Year Longitudinal Assessment of 22 New Molecular Entities Approved in 2008 by the US Food and Drug Administration.
    Croteau D; Pinnow E; Wu E; Muñoz M; Bulatao I; Dal Pan G
    Drug Saf; 2022 Feb; 45(2):169-180. PubMed ID: 35113347
    [TBL] [Abstract][Full Text] [Related]  

  • 25. US Food and Drug Administration regulatory reviewer disagreements and postmarket safety actions among new therapeutics.
    Eadie A; MacGregor A; Wallach J; Ross J; Herder M
    BMJ Evid Based Med; 2023 Jun; 28(3):151-156. PubMed ID: 36944478
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Postmarket Modifications of High-Risk Therapeutic Devices in Otolaryngology Cleared by the US Food and Drug Administration.
    Rathi VK; Ross JS; Samuel AM; Mehra S
    Otolaryngol Head Neck Surg; 2015 Sep; 153(3):400-8. PubMed ID: 26044785
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A Pharmacovigilance Signaling System Based on FDA Regulatory Action and Post-Marketing Adverse Event Reports.
    Hoffman KB; Dimbil M; Tatonetti NP; Kyle RF
    Drug Saf; 2016 Jun; 39(6):561-75. PubMed ID: 26946292
    [TBL] [Abstract][Full Text] [Related]  

  • 28. US Congress considers new tracking system for medical devices after excessive recalls.
    Epstein K
    BMJ; 2012 Apr; 344():e2915. PubMed ID: 22529316
    [No Abstract]   [Full Text] [Related]  

  • 29. Medical device reporting: manufacturer reporting, importer reporting, user facility reporting, and distributor reporting--FDA. Direct final rule.
    Fed Regist; 1998 May; 63(91):26069-77. PubMed ID: 10179334
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Strengthening the Evidence Base for Pediatric Medical Devices Using Real-World Data.
    Fleurence RL; Forrest CB; Shuren J
    J Pediatr; 2019 Nov; 214():209-211. PubMed ID: 31378521
    [No Abstract]   [Full Text] [Related]  

  • 31. Medical devices; medical device user facility and manufacturer reporting, certification and registration; Office of Management and Budget approval; extension of effective date--FDA. Final rule; notification of approval of information collection requirements.
    Fed Regist; 1996 Apr; 61(71):16043-5. PubMed ID: 10157704
    [No Abstract]   [Full Text] [Related]  

  • 32. Reporting Device-Associated Death Events to the FDA.
    Ryan M; Myers AM; Yustein AS
    JAMA Intern Med; 2022 Apr; 182(4):462. PubMed ID: 35188525
    [No Abstract]   [Full Text] [Related]  

  • 33. Risk of Recall Among Medical Devices Undergoing US Food and Drug Administration 510(k) Clearance and Premarket Approval, 2008-2017.
    Dubin JR; Simon SD; Norrell K; Perera J; Gowen J; Cil A
    JAMA Netw Open; 2021 May; 4(5):e217274. PubMed ID: 33956132
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Reporting Device-Associated Death Events to the FDA-Reply.
    Lalani C; Kinard M; Redberg RF
    JAMA Intern Med; 2022 Apr; 182(4):462-463. PubMed ID: 35188530
    [No Abstract]   [Full Text] [Related]  

  • 35. Safe Medical Devices Act: management guidance for hospital compliance with the new FDA requirements.
    Alder HC
    Hosp Technol Ser; 1993 Oct; 12(11):1-27. PubMed ID: 10129209
    [TBL] [Abstract][Full Text] [Related]  

  • 36. FDA Regulation and Approval of Medical Devices: 1976-2020.
    Darrow JJ; Avorn J; Kesselheim AS
    JAMA; 2021 Aug; 326(5):420-432. PubMed ID: 34342614
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Trials of transvaginal mesh devices for pelvic organ prolapse: a systematic database review of the US FDA approval process.
    Heneghan CJ; Goldacre B; Onakpoya I; Aronson JK; Jefferson T; Pluddemann A; Mahtani KR
    BMJ Open; 2017 Dec; 7(12):e017125. PubMed ID: 29212782
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Analysis of the Food and Drug Administration Manufacturer and User Facility Device Experience Database for Patient- and Circuit-Related Adverse Events Involving Extracorporeal Membrane Oxygenation.
    Khalid N; Javed H; Ahmad SA; Edelman JJ; Shlofmitz E; Chen Y; Musallam A; Rogers T; Hashim H; Bernardo NL; Waksman R
    Cardiovasc Revasc Med; 2020 Feb; 21(2):230-234. PubMed ID: 31767523
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Completion Rate and Reporting of Mandatory Pediatric Postmarketing Studies Under the US Pediatric Research Equity Act.
    Hwang TJ; Orenstein L; Kesselheim AS; Bourgeois FT
    JAMA Pediatr; 2019 Jan; 173(1):68-74. PubMed ID: 30452498
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Association Between Regulatory Submission Characteristics and Recalls of Medical Devices Receiving 510(k) Clearance.
    Everhart AO; Sen S; Stern AD; Zhu Y; Karaca-Mandic P
    JAMA; 2023 Jan; 329(2):144-156. PubMed ID: 36625811
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.